抗氰呼吸交替氧化酶研究进展

抗氰呼吸交替氧化酶研究进展梁五生梁厚果（兰州大学生物系,兰州７３００００）ＰＲＯＧＲＥＳＳＯＦＴＨＥＳＴＵＤＹＯＮＡＬＴＥＲＮＡＴＩＶＥＯＸＩＤＡＳＥＬｉａｎｇＷｕ－ｓｈｅｎｇＬｉａｎｇＨｏｕ－ｇｕｏ（ＢｉｏｌｏｇｙＤｅｐａｒｔｍｅｎｔ,Ｌａｎｚｈ...     

交替氧化酶结构和功能研究进展

交替氧化酶(a lternative ox idase,AOX)是植物线粒体呼吸链中抗氰呼吸途径(cyan ide-res istan t resp irationpathw ay)的末端氧化酶,它广泛存在于高等植物及部分真菌和藻类中。交替氧化酶是一种双铁羧基蛋白(d i-ironcarboxy late prote in),它不仅具有其它双铁羧基蛋白共有的结构特点以及去除分子氧的功能,更重要的是它还可以通过改变自身结构等方式来主动调节抗氰呼吸途径的运行程度,进而调节细胞多方面的代谢和功能,以适应环境条件的改变,增强植物适应各种逆境的能力,调节植物生长速率,并与细胞凋亡和光合作用相关。本文主要对交替氧化酶的结构与其在植物体内功能的最新研究进展进行综述。     

用合成多肽制备抗体研究绿豆抗氰呼吸与交替氧化酶表达关系

按照交替氧化酶(alternative oxidase,AOX)位于线粒体内膜外侧亲水区S螺旋的氨基酸序列,用固相法合成由12个氨基酸残基组成的多肽,将此多肽与α-牛胰凝乳蛋白酶原A相连,用作半抗原,免疫家兔制备人工合成12肽的抗体.将此抗体与来自绿豆幼苗不同器官线粒体的总蛋白分别进行Western杂交,可观察到绿豆幼苗线粒体中具有两条清晰的AOX杂交带,它们的分子量分别为35和38 ku.同时,取绿豆幼苗的子叶、真叶和下胚轴,分别测定和计算它们的呼吸参数,可以得知真叶器官组织具有最大的总呼吸(V_t)、交替途径容量(V_alt)及交替途径实际运行量(ρV_alt);其次是子叶的V_t和ρV_alt;下胚轴的V_t和ρV_alt最低,但是V_alt却高于子叶.绿豆幼苗不同器官的有关呼吸参数测定结果与AOX表达的Western分析基本一致:真叶的V_t特别是ρV_alt最高,也具有35和38 ku的AOX的杂交多肽; 其次是子叶的V_t和ρV_alt,且在子叶中,只见一条分子量为38 ku的AOX多肽;下胚轴的V_alt和ρV_alt都最低,Western杂交显示只有一条分子量为38ku的多肽,而且表达量较少.35 ku的AOX可能对真叶的ρV_alt作出了主要贡献.     

水分胁迫对小麦幼苗抗氰呼吸和交替氧化酶基因表达的影响

抗氰呼吸作为植物线粒体的两条主要呼吸电子传递途径之一,已证明在植物界普遍存在,与植物的许多生理过程和功能密切相关;它的发生或运行程度除与植物自身发育和内在生理状态有关外,还受许多外界条件（逆境因子）的影响［１～３］。有证据表明,机械损伤［４］、高温［...     

高等植物的交替氧化酶研究进展

交替氧化酶(Alternative Oxidase,AOX)广泛存在于高等植物、藻类和原生生物线粒体内膜。从主呼吸链的辅酶Q分岔,是氧化辅酶Q、还原氧分子生成水的另一终端氧化酶。氧化过程没有质子穿膜运动、热量以产热方式散发。产热植物中交替氧化产生的热量使花粉发出芳香味吸引虫传粉。推测植物AOX使植物在环境胁迫下维持呼吸,调节能量平衡,抵抗氧化胁迫,保持三羧酸循环的运行。AOX是首次发现的双铁羧酸蛋白质成员中的膜蛋白质,AOX与膜分离后容易失活,至今尚未有三级结构的报导,只有二级结构的2种假设模式,最新的模式AOX为膜界面蛋白质而不是跨膜蛋白。最近我们的研究表明有2个途径可获得适量有活性的AOX:建立优化的pFLAG-1-AOX大肠杆菌超量表达系统;从产热植物如斑叶阿若母(Arum maculatum)花序组织线粒体分离纯化有活性的AOX。     

不同低温胁迫对烟草愈伤组织抗氰交替途径诱导和交替氧化酶表达影响的比较

比较了不同低温（14℃和4℃）胁迫对烟草（Nicotiana rustica L.）愈伤组织抗氰交替途径诱导和交替氧化酶表达的影响。结果显示,不同低温胁迫处理能显著诱导烟草愈伤组织交替途径容量和实际运行的增加,且都呈现出基本相同的变化模式：在胁迫的初期（1～3 d）持续增加,在3 d时达到最高,而后下降到一个相对恒定的水平。但交替途径容量增加的幅度与温度下降的程度密切相关,而交替途径实际运行量的诱导程度在不同低温胁迫下的差异却很小。表明交替途径容量和实际运行对低温胁迫的响应是不同的。免疫印迹分析结果表明：低温胁迫明显诱导了交替氧化酶总蛋白的增加,且其随低温胁迫进程的变化与交替途径容量的变化基本一致;而对交替氧化酶单体与二聚体在低温胁迫下的含量变化检测结果则显示,烟草愈伤组织中交替氧化酶主要以二聚体形式存在,且这一存在形式并不随低温胁迫程度的加深而发生改变。两种形式的交替氧化酶蛋白含量都能被低温胁迫诱导增加,但其单体水平在两种不同的低温胁迫下并无明显差别,而4℃低温胁迫诱导的二聚体交替氧化酶蛋白含量明显高于14℃。表明不同程度低温对抗氰交替途径发生的不同影响主要是由于对交替氧化酶蛋白二聚体形式的不同诱导程度所致;而高活性的交替氧化酶单体形式则不因低温胁迫程度的加重而被明显诱导升高,使得抗氰交替途径的运行程度在两种不同的低温胁迫处理条件下无显著差异。     

不同低温胁迫对烟草愈伤组织抗氰交替途径诱导和交替氧化酶表达影响的比较

比较了不同低温(14℃和4℃)胁迫对烟草(Nicotiana rusticaL．)愈伤组织抗氰交替途径诱导和交替氧化酶表达的影响。结果显示,不同低温胁迫处理能显著诱导烟草愈伤组织交替途径容量和实际运行的增加,且都呈现出基本相同的变化模式：在胁迫的初期(1—3d)持续增加,在3d时达到最高,而后下降到一个相对恒定的水平。但交替途径容量增加的幅度与温度下降的程度密切相关,而交替途径实际运行量的诱导程度在不同低温胁迫下的差异却很小。表明交替途径容量和实际运行对低温胁迫的响应是不同的。免疫印迹分析结果表明：低温胁迫明显诱导了交替氧化酶总蛋白的增加,且其随低温胁迫进程的变化与交替途径容量的变化基本一致;而对交替氧化酶单体与二聚体在低温胁迫下的含量变化检测结果则显示,烟草愈伤组织中交替氧化酶主要以二聚体形式存在,且这一存在形式并不随低温胁迫程度的加深而发生改变。两种形式的交替氧化酶蛋白含量都能被低温胁迫诱导增加,但其单体水平在两种不同的低温胁迫下并无明显差别,而4℃低温胁迫诱导的二聚体交替氧化酶蛋白含量明显高于14℃。表明不同程度低温对抗氰交替途径发生的不同影响主要是由于对交替氧化酶蛋白二聚体形式的不同诱导程度所致;而高活性的交替氧化酶单体形式则不因低温胁迫程度的加重而被明显诱导升高,使得抗氰交替途径的运行程度在两种不同的低温胁迫处理条件下无显著差异。     

番茄交替氧化酶基因的克隆和表达

利用简并PCR扩增产物做探针筛选番茄cDNA基因文库获得一个全长交替氧化酶cDNA基因LeAoxlau.经序列分析得出,该基因全长1 418bp,编码区序列长1 077 bp,编码约40 kD的前体蛋白.该蛋白在转运到线粒体时被加工成32kD的成熟蛋白.Southern印迹杂交分析结果显示该基因以单拷贝形式存在于番茄的基因组中RT-PCR显示,该基因在在番茄植株的根、茎、叶和子叶中表达.重组表达实验表明该基因能在大肠杆菌中表达.     

环境胁迫与植物抗氰呼吸

抗氰呼吸广泛存在于高等植物、一些真菌和藻类中。抗氰呼吸的发生和运行程度除与植物自身发育和内在生理状态有关外,还受到许多外界条件（逆境因子）的影响。目前,有关植物抗氰呼吸的环境调节以及环境胁迫条件下植物抗氰交替途径运行的生理学意义已成为植物呼吸代谢领域的研究热点。本研究综述了环境胁迫与植物抗氰呼吸的研究进展。     

小球藻高附加值生物活性物质“小球藻热水提取物”的研究现状与展望

小球藻是一种食用历史久、营养丰富的微藻功能食品,其中蛋白核小球藻已于2012年被我国批准为新资源食品,并成为国内外正在大力发展与培育的微藻能源及微藻固碳这一战略性新兴产业的主要藻种之一。在积累油脂的同时,小球藻自身还能合成高附加值生物活性物质,其合理利用可平衡微藻能源的高成本。小球藻热水提取物(CE),即商业上宣称的"小球藻生长因子(CGF)",是小球藻有别于其他微藻的主要生物活性物质,在促进生长、调节免疫等方面具有良好功效,且市场售价高。但迄今,有关CE的认识尚不清晰,尚未见CE方面的系统评述。本文对近年来CE的活性研究状况进行了系统的文献调查与梳理,综述了CE在增强免疫、抑制肿瘤、改善代谢综合征、清除自由基、抵御紫外损伤、螯合重金属以及保肝护肠等多个方面的功效,并分析了CE活性研究中存在的问题及CE的发展前景。     

小球藻热水提取物功能成分的活性跟踪分离

本研究旨在以自由基清除作用和促巨噬细胞增殖作用为导向,对小球藻热水提取物(CPE)的分离纯化产物进行活性跟踪,以确定CPE的主要功能成分。采用高压热水提取、Sevag除蛋白、乙醇沉淀和超滤的方法得到CPE粗多糖,然后通过DEAE52离子交换层析柱和Sephadex G-100对CPE粗多糖组分进一步分离纯化。研究结果表明,通过上述方法对CPE进行分离纯化,得到3种高活性成分PS-1-4-2、PS-1-3-2和PS-2-3-3,经凝胶渗透色谱GPC分析得知其分子质量分别为3.97×10~4 Da、2.28×10~4 Da和4.1×10~3 Da。活性跟踪结果表明,CPE能够清除自由基并促进巨噬细胞Ana-1细胞生长,主要是由于其多种活性组分共同发挥作用,清除自由基作用的功能成分主要集中于PS-1-3、PS-1-4、PS-2-3和PS-2-4,促Ana-1细胞增殖作用的功能成分主要集中于PS-1-3、PS-1-4和PS-2-3。本研究确立了CPE主要功能成分的活性筛选手段,并获得3种新型功能成分,可用于指导小球藻高附加值产品的开发,从而进一步推动微藻能源的产业化进程,实现"高附加值微藻产品、微藻能源与微藻固碳"一体化的示范作用。     

A screening model to predict microalgae biomass growth in photobioreactors and raceway ponds

A microalgae biomass growth model was developed for screening novel strains for their potential to exhibit high biomass productivities under nutrient‐replete conditions in photobioreactors or outdoor ponds. Growth is modeled by first estimating the light attenuation by biomass according to Beer‐Lambert's Law, and then calculating the specific growth rate in discretized culture volume slices that receive declining light intensities due to attenuation. The model uses only two physical and two species‐specific biological input parameters, all of which are relatively easy to determine: incident light intensity, culture depth, as well as the biomass light absorption coefficient and the specific growth rate as a function of light intensity. Roux bottle culture experiments were performed with Nannochloropsis salina at constant temperature (23°C) at six different incident light intensities (10, 25, 50, 100, 250, and 850 µmol/m² s) to determine both the specific growth rate under non‐shading conditions and the biomass light absorption coefficient as a function of light intensity. The model was successful in predicting the biomass growth rate in these Roux bottle batch cultures during the light‐limited linear phase at different incident light intensities. Model predictions were moderately sensitive to minor variations in the values of input parameters. The model was also successful in predicting the growth performance of Chlorella sp. cultured in LED‐lighted 800 L raceway ponds operated in batch mode at constant temperature (30°C) and constant light intensity (1,650 µmol/m² s). Measurements of oxygen concentrations as a function of time demonstrated that following exposure to darkness, it takes at least 5 s for cells to initiate dark respiration. As a result, biomass loss due to dark respiration in the aphotic zone of a culture is unlikely to occur in highly mixed small‐scale photobioreactors where cells move rapidly in and out of the light. By contrast, as supported also by the growth model, biomass loss due to dark respiration occurs in the dark zones of the relatively less well‐mixed pond cultures. In addition to screening novel microalgae strains for high biomass productivities, the model can also be used for optimizing the pond design and operation. Additional research is needed to validate the biomass growth model for other microalgae species and for the more realistic case of fluctuating temperatures and light intensities observed in outdoor pond cultures. Biotechnol. Bioeng. 2013; 110: 1583–1594. © 2012 Wiley Periodicals, Inc.     

白囊耙齿菌子实体提取物对小鼠慢性肾小球肾炎的预防与治疗

本文对白囊耙齿菌子实体不同提取物防治慢性肾小球肾炎进行研究,采用腺嘌呤灌胃法建立小鼠慢性肾小球肾炎模型,探究白囊耙齿菌子实体水提取物和醇提取物的高、中、低剂量组对慢性肾小球肾炎的预防作用及不同提取物的高剂量组对慢性肾小球肾炎的治疗作用,并对小鼠体重进行测量,检测尿蛋白(UP)、尿素氮(BUN)、肌酐(Cr)、总胆固醇(TC)、超氧歧化酶(SOD)、一氧化氮(NO)、丙二醛(MDA)、白介素-6(IL-6)、白介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)指标,分析肾、肝、脾、胸腺的病理变化。结果表明,水提取物中剂量(240mg/kg)能显著降低小鼠尿蛋白含量和肾组织中炎症因子含量,使血清生化指标维持正常,并对免疫器官有保护作用;醇提取物高剂量(200mg/kg)对慢性肾小球肾炎有治疗作用,但对免疫器官保护作用较弱。研究表明,白囊耙齿菌子实体水提取物中剂量具有预防慢性肾小球肾炎的作用且效果优于阳性药肾炎康胶囊,具有开发利用潜力,机制有待于进一步研究。     

Synthesis and in vitro bioactivity of human growth hormone-releasing factor analogs substituted at position-1

Eight position-1 analogs of the 40-amino acid fragment and two position-1 analogs of human growth hormone-releasing factor were synthesized by solid phase methodology and their capacity to release growth hormone was determined using rat anterior pituitary cells in monolayer culture. Relative to hGRF(1-40)OH, which was arbitrarily assigned a potency value of 1, [D-Tyr1]hGRF(1-40)OH, [Phe1]hGRF(1-40)OH, [Trp1]hGRF(1-40)OH, [His1]hGRF(1-40)OH, [Ala1]hGRF(1-40)OH, [(-Ac)Tyr1]hGRF(1-40)OH, Arg0-hGRF(1-40)OH and Ala0-hGRF(1-40)OH have potencies of 0.022, 0.038, 0.003, 0.351, 0.010, 0.032, 0.002 and 0.007 respectively. Relative to hGRF(1-44)NH2 = 1, [(3-Me)His1]hGRF(1-44)NH2 and [(O-Me)Tyr1]hGRF(1-44)NH2 have potencies of 0.132 and 0.001 respectively. These results demonstrate the prerequisite for an aromatic residue at position-1 for potent biological activity and also suggest that the capacity for hydrogen bond formation with the first residue is required for full receptor-ligand interaction.     

EPO对高脂喂养小鼠棕色脂肪组织PRDM16、FGF21表达及STAT3磷酸化水平的影响

目的：探索促红细胞生成素（EPO）对高脂饲料（HFD）喂养小鼠血糖和血浆胰岛素水平、胰岛素抵抗指数（HOMA-IR）、糖耐量,以及棕色脂肪组织中含PR结构域蛋白16（PRDM16）、信号转导与转录激活因子3（STAT3）磷酸化水平（p-STAT3/STAT3）、成纤维细胞生长因子21（FGF21）mRNA以及蛋白质表达的影响,为肥胖及其并发症的发生机制提供线索。方法：20只高脂饲料喂养的C57BL/6J雄性小鼠随机分为对照组（HFD-Con）和EPO组（HFD-EPO）,两组分别腹腔注射生理盐水和EPO（200 IU/kg）,每周3次,连续4周。4周后检测两组动物的体重、血糖与血浆胰岛素水平、HOMA-IR及糖耐量的变化;分别使用实时定量PCR法和Western blot法检测棕色脂肪组织中PRDM16、STAT3、FGF21 mRNA和蛋白质水平。结果：腹腔注射EPO 4周后,HFD-EPO组小鼠体重为（26.65±0.85）g,HFD-Con组体重为（31.50±1.60）g,P<0.01。HFD-Con组血糖为（91.06±9.86）mg/dl,HFD-EPO组为（62.79±8.09）mg/dl,P<0.01;HFD-EPO组小鼠血浆胰岛素水平为（10.56±1.06）μU/ml,HFD-Con组为（13.2±1.1）μU/ml,P<0.01。与HFD-Con组比较,HFD-EPO组的糖耐量水平显著改善,胰岛素抵抗指数下降;HFD-EPO组动物棕色脂肪组织中PRDM16、FGF21mRNA以及蛋白质表达,p-STAT/STAT3水平均显著增加,两组小鼠肝脏中FGF21 mRNA含量、血浆中FGF21含量无明显差异。结论：EPO可能通过增加棕色脂肪组织中PRDM16表达促进棕色脂肪组织的分化,降低高脂喂养小鼠的血糖水平、改善高脂喂养小鼠的糖代谢状态。     

Cloning and functional expression in E. coli of a polyphenol oxidase transcript from Coreopsis grandiflora involved in aurone formation

Polyphenol oxidases are involved in aurone biosynthesis but the gene responsible for 4-deoxyaurone formation in Asteraceae was so far unknown. Three novel full-length cDNA sequences were isolated from Coreopsis grandiflora with sizes of 1.80 kb (cgAUS1) and 1.85 kb (cgAUS2a, 2b), encoding for proteins of 68–69 kDa, respectively. cgAUS1 is preferably expressed in young petals indicating a specific role in pigment formation. The 58.9 kDa AUS1 holoproenzyme, was recombinantly expressed in E. coli and purified to homogeneity. The enzyme shows only diphenolase activity, catalyzing the conversion of chalcones to aurones and was characterized by SDS–PAGE and shot-gun type nanoUHPLC–ESI-MS/MS.     

Brain edema in diseases of different etiology

Cerebral edema is a potentially life-threatening complication shared by diseases of different etiology, such as diabetic ketoacidosis, acute liver failure, high altitude exposure, dialysis disequilibrium syndrome, and salicylate intoxication. Pulmonary edema is also habitually present in these disorders, indicating that the microcirculatory disturbance causing edema is not confined to the brain. Both cerebral and pulmonary subclinical edema may be detected before it becomes clinically evident. Available evidence suggests that tissue hypoxia or intracellular acidosis is a commonality occurring in all of these disorders. Tissue ischemia induces physiological compensatory mechanisms to ensure cell oxygenation and carbon dioxide removal from tissues, including hyperventilation, elevation of red blood cell 2,3-bisphosphoglycerate content, and capillary vasodilatation. Clinical, laboratory, and necropsy findings in these diseases confirm the occurrence of low plasma carbon dioxide partial pressure, increased erythrocyte 2,3-bisphosphoglycerate concentration, and capillary vasodilatation with increased vascular permeability in all of them. Baseline tissue hypoxia or intracellular acidosis induced by the disease may further deteriorate when tissue oxygen requirement is no longer matched to oxygen delivery resulting in massive capillary vasodilatation with increased vascular permeability and plasma fluid leakage into the interstitial compartment leading to edema affecting the brain, lung, and other organs. Causative factors involved in the progression from physiological adaptation to devastating clinical edema are not well known and may include uncontrolled disease, malfunctioning adaptive responses, or unknown factors. The role of carbon monoxide and local nitric oxide production influencing tissue oxygenation is unclear.     

Differential phosphopeptide expression in a benign breast tissue, and triple-negative primary and metastatic breast cancer tissues from the same African-American woman by LC-LTQ/FT-ICR mass spectrometry

African-American women have a higher risk for developing triple-negative breast cancer (TNBC). Lacking the expression of receptors for estrogen and progesterone, and without human epidermal growth factor 2 receptor gene amplification, TNBC is a very aggressive type of breast cancer with a high likelihood of metastasis and recurrence. Specific therapeutic targets for this aggressive disease remain to be identified. Phosphorylation, a post-translational modification that adds one or more phosphate groups to a protein, plays a key role in the activation and deactivation of a protein’s cellular function. Here, we report the first systematic phosphoproteomic analysis of a benign breast tissue, a primary breast cancer tissue, and a metastatic breast cancer tissue from the same African-American woman. Differential phosphoprotein levels were measured with reversed-phase nano-liquid chromatography coupled to a hybrid linear quadrupole ion trap/Fourier transform ion cyclotron resonance mass spectrometer (LC-LTQ/FT-ICR MS). Five proteins were found to be highly phosphorylated in the metastatic site whereas six proteins were highly phosphorylated in the cancer site of the TNBC patient. Identified phosphoproteins are known to be involved in breast cancer signal transduction pathways and these results may identify new diagnostic and therapeutic targets for TNBC.